FDA Commissioner Makary Says He Will Leave Access To Mifepristone As Is
During an appearance at the Semafor World Economy Summit on Thursday, Makary stated that he would reexamine the issue if new data emerged regarding the safety of the drug, Bloomberg reported. In other news, the ACLU and NFPRHA are suing the Trump administration for withholding Title X funds; the Pentagon will resume gender-affirming care; and more.